Transglutaminase 2: An enigmatic enzyme with diverse functions

Trends in Biochemical Sciences

Volumn 27, Issue 10, 2002, Pages 534-539

  Fesus, Laszlo ^a   Piacentini, Mauro ^b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; GUANINE NUCLEOTIDE BINDING PROTEIN; ISOENZYME; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

APOPTOSIS; BINDING SITE; CATALYSIS; CELIAC DISEASE; CELL ADHESION; CYTOSKELETON; ENZYME ACTIVATION; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HUMAN; NERVE DEGENERATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN MOTIF; REVIEW; SIGNAL TRANSDUCTION;

AMINO ACID MOTIFS; AMINO ACIDS; ANIMALS; BINDING SITES; GTP-BINDING PROTEINS; HUMANS; MICE; MODELS, MOLECULAR; PROTEIN BINDING; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSGLUTAMINASES;

EID: 0036804796     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0004(02)02182-5     Document Type: Review

References (65)

1. Sarkar N.K., et al. An enzymically catalyzed incorporation of amines into proteins. Biochim. Biophys. Acta. 25:1957;451-452.
2. Lorand L. Transglutaminase. Remembering Heinrich Waelsch. Neurochem. Int. 40:2002;7-12.
3. Folk J.E., Finlayson J.S. The epsilon-(gamma-glutamyl)lysine crosslink and the catalytic role of transglutaminases. Adv. Protein Chem. 31:1977;1-133.
4. Grenard P., et al. Evolution of transglutaminase genes: identification of a transglutaminase gene cluster on human chromosome 15q15. J. Biol. Chem. 276:2001;33066-33078.
5. Nakaoka H., et al. Gh: a GTP-binding protein with transglutaminase activity and receptor signaling function. Science. 264:1994;1593-1596.
6. Achyuthan K.E., et al. Identification of a guanosine triphosphate-binding site on guinea pig liver transglutaminase. Role of GTP and calcium ions in modulating activity. J. Biol. Chem. 262:1987;1901-1906.
7. Liu S., et al. Structural basis for the guanine nucleotide-binding activity of tissue transglutaminase and its regulation of transamidation activity. Proc. Natl. Acad. Sci. U. S. A. 99:2002;2743-2747.
8. Yee V.C., et al. Three-dimensional structure of a transglutaminase: human blood coagulation factor XIII. Proc. Natl. Acad. Sci. U. S. A. 91:1994;7296-7300.
9. Murthy S.N., et al. Conserved tryptophan in the core domain of transglutaminase essential for catalytic activity. Proc. Natl. Acad. Sci. U. S. A. 99:2002;2738-2742.
10. Hwang K-C., et al. Interaction site of GTP binding Gh (transglutaminase II) with phospholipase C. J. Biol. Chem. 270:1995;27058-27062.
11. h/transglutaminase II involves distinct residues in a unique GTP-binding pocket. J. Biol. Chem. 275:2000;18259-18265.
12. Fox B.A., et al. Identification of the calcium binding site and a novel ytterbium site in blood coagulation factor XIII by X-ray crystallography. J. Biol. Chem. 274:1999;4917-4923.
13. 43Ca NMR study combined with surface polarity analysis. J. Biomol. Struct. Dyn. 19:2001;59-74.
14. Noguchi K., et al. Crystal structure of red sea bream transglutaminase. J. Biol. Chem. 276:2001;12055-12059.
15. Mariani P., et al. Ligand-induced conformational changes in tissue transglutaminase: Monte Carlo analysis of small-angle scattering data. Biophys. J. 78:2000;3240-3251.
16. Ahvazi B., et al. Three-dimensional structure of the human transglutaminase 3 enzyme: binding of calcium ions changes structure for activation. EMBO J. 21:2002;2055-2067.
17. Weiss M.S., et al. Two non-proline cis peptide bonds may be important for factor XIII function. FEBS Lett. 423:1998;291-296.
18. Gaudry C.A., et al. Cell surface localization of tissue transglutaminase is dependent on a fibronectin-binding site in its N-terminal β-sandwich domain. J. Biol. Chem. 274:1999;30707-30714.
19. Peng X., et al. Interaction of tissue transglutaminase with nuclear transport protein importin-α3. FEBS Lett. 5:1999;35-39.
20. Thomázy V., Fesus L. Differential expression of tissue transglutaminase in human cells: an immunohistochemical study. Cell Tissue Res. 255:1989;215-224.
21. Szegezdi E., et al. Apoptosis-linked in vivo regulation of the tissue transglutaminase gene promoter. Cell Death Differ. 7:2000;1225-1233.
22. Murthy S.N., et al. Interaction of G(h)/transglutaminase with phospholipase Cδ1 and with GTP. Proc. Natl. Acad. Sci. U. S. A. 96:1999;11815-11819.
23. Lai T.S., et al. Sphingosylphosphocholine reduces the calcium ion requirement for activating tissue transglutaminase. J. Biol. Chem. 272:1997;16295-16300.
24. Lesort M., et al. Tissue transglutaminase: a possible role in neurodegenerative diseases. Prog. Neurobiol. 61:2000;439-463.
25. Lai T.S., et al. Calcium regulates S-nitrosylation, denitrosylation, and activity of tissue transglutaminase. Biochemistry. 40:2001;4904-4910.
26. Singh U.S., et al. Role of transglutaminase II in retinoic acid-induced activation of RhoA-associated kinase-2. EMBO J. 20:2001;2413-2423.
27. Piredda L., et al. Identification of 'tissue' transglutaminase binding proteins in neural cells committed to apoptosis. FASEB J. 13:1999;355-364.
28. Murthy S.N., et al. Cross-linking sites of the human tau protein, probed by reactions with human transglutaminase. J. Neurochem. 71:1998;2607-2614.
29. Singh U.S., et al. Identification and biochemical characterization of an 80 kilodalton GTP-binding/transglutaminase from rabbit liver nuclei. Biochemistry. 34:1995;15863-15874.
30. Ballestar E., et al. Conformational changes in the nucleosome followed by the selective accessibility of histone glutamines in the transglutaminase reaction: effects of salt concentrations. Biochemistry. 40:2001;1922-1929.
31. Oliverio S., et al. Tissue transglutaminase-dependent posttranslational modification of the retinoblastoma gene product in promonocytic cells undergoing apoptosis. Mol. Cell. Biol. 17:1997;6040-6048.
32. Fesus L., et al. Induction and activation of tissue transglutaminase during programmed cell death. FEBS Lett. 224:1987;104-108.
33. Oliverio S., et al. Inhibition of 'tissue' transglutaminase increases cell survival by preventing apoptosis. J. Biol. Chem. 274:1999;34123-34128.
34. Piacentini M., et al. Transglutaminase overexpression sensitizes neuronal cell lines to apoptosis by increasing mitochondrial membrane potential and cellular oxidative stress. J. Neurochem. 81:2002;1061-1072.
35. Nemes Z., et al. Identification of cytoplasmic actin as an abundant glutaminyl substrate for tissue transglutaminase in HL-60 and U937 cells undegoing apoptosis. J. Biol. Chem. 33:1997;20577-20583.
36. Fesus L., et al. Apoptotic hepatocytes become insoluble in detergents and chaotropic agents as a result of transglutaminase action. FEBS Lett. 245:1989;150-154.
37. Piredda L., et al. Lack of 'tissue' transglutaminase protein cross-linking leads to leakage of macromolecules from dying cells: relationship to development of autoimmunity in MRLlpr/lpr mice. Cell Death Differ. 4:1997;463-472.
38. Griffin M., Verderio E. Tissue transglutaminase in cell death. Bryant J.A., Hughes S.G., Galand J.M., Programmed cell death in animals and plants. 2000;223-238 Bios Scientific Publications.
39. Akimov S.S., Belkin A.M. Cell-surface transglutaminase promotes fibronectin assembly via interaction with the gelatin-binding domain of fibronectin: a role in TGFβ-dependent matrix deposition. J. Cell Sci. 114:2001;2989-3000.
40. Balklava Z., et al. Analysis of tissue transglutaminase function in the migration of Swiss fibroblasts. The active-state conformation of the enzyme does not affect cell motility but it is important for its secretion. J. Biol. Chem. 277:2002;16567-16575.
41. Haroon Z.A., et al. Tissue transglutaminase is expressed, active, and directly involved in rat dermal wound healing and angiogenesis. FASEB J. 13:1999;1787-1795.
42. Aeschlimann D., Thomazy V. Protein crosslinking in assembly and remodelling of extracellular matrices: The role of transglutaminases. Connect. Tissue Res. 41:1999;1-27.
43. Sakai K., et al. Tissue transglutaminase facilitates the polymerization of insulin-like growth factor-binding protein-1 (IGFBP-1) and leads to loss of IGFBP-1's ability to inhibit insulin-like growth factor-I-stimulated protein synthesis. J. Biol. Chem. 276:2001;8740-8745.
44. Nunes I., et al. Latent transforming growth factor β binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-beta. J. Cell Biol. 136:1997;1151-1163.
45. Ritter S.J., Davies P.J. Identification of a transforming growth factor-beta/bone morphogenic protein 4 (TGF-beta/BMP4) response element within the mouse tissue transglutaminase gene promoter. J. Biol. Chem. 263:1998;4586-4592.
46. De Laurenzi V., Melino G. Gene disruption of tissue transglutaminase. Mol. Cell. Biol. 21:2001;148-155.
47. h/tissue transglutaminase II. J. Biol. Chem. 276:2001;20673-20678.
48. Bernassola, M. et al. Role of transglutaminase 2 in glucose tolerance. FASEB J. (in press)
49. Anderson R.P., et al. In vivo antigen challenge in coeliac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope. Nat. Med. 6:2000;337-342.
50. Willemijn L., et al. Specificity of tissue transglutaminase explains cereal toxicity in coeliac disease. J. Exp. Med. 195:2002;643-649.
51. Dietrich W., et al. Identification of tissue transglutaminase as the autoantigene of celiac disease. Nat. Med. 3:1997;797-801.
52. Skill N.J., et al. Increases in renal ε(γ-glutamyl)lysine crosslinks result from compartment-specific changes in tissue transglutaminase in early experimental diabetic nephropathy: pathologic implications. Lab. Invest. 81:2001;705-716.
53. Mastroberardino P.G., et al. Tissue transglutaminase ablation reduces neuronal death and prolongs survival in a mouse model of Huntington's disease. Cell Death Differ. 9:2002;873-880.
54. Citron B.A., et al. Intron-exon swapping of transglutaminase mRNA and neuronal tau aggregation in Alzheimer's disease. J. Biol. Chem. 276:2001;3295-3301.
55. a. J. Biol. Chem. 272:1997;10311-10317.
56. Radek J.T., et al. Affinity of human erythrocyte transglutaminase for a 42-kDa gelatin-binding fragment of human plasma fibronectin. Proc. Natl. Acad. Sci. U. S. A. 90:1993;3152-3156.
57. Isobe T., et al. Activity-independent cell adhesion to tissue-type transglutaminase is mediated by α4β1 integrin. Eur. J. Cell Biol. 78:1999;876-883.
58. Hebert S.S., et al. The mixed lineage kinase DLK is oligomerized by tissue transglutaminase during apoptosis. J. Biol. Chem. 275:2000;32482-32490.
59. Kojima S., et al. Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cells. J. Cell Biol. 121:1993;439-448.
60. McKanna J.A. Lipocortin 1 in apoptosis: mammary regression. Anat. Rec. 242:1995;1-10.
61. Eligula L., et al. Transglutaminase-induced cross-linking between subdomain 2 of G-actin and the 636-642 lysine-rich loop of myosin subfragment 1. Biophys. J. 74:1998;953-963.
62. Huff T., et al. Thymosin beta(4) serves as a glutaminyl substrate of transglutaminase. Labelling with fluorescent dansylcadaverine does not abolish interaction with G-actin. FEBS Lett. 464:1999;14-20.
63. Grierson A.J., et al. Three different human tau isoforms and rat neurofilament light, middle and heavy chain proteins are cellular substrates for transglutaminase. Neurosci. Lett. 298:2001;9-12.
64. Ruse M., et al. S100A7, S100A10, and S100A11 are transglutaminase substrates. Biochemistry. 40:2001;3167-3173.
65. Piacentini M., Colizzi V. Tissue transglutaminase: apoptosis versus autoimmunity. Immunol. Today. 20:1999;130-134.